Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
COGT
Home
/
COGT

NASDAQ
$31.49
$31.49

Overview

Price performance
Low
$29.93
High
$32.03
Market closed. Last updated: Nov 4, 2026, 9:00 PM UTC
$
31.49
0.43 (1.38%)
Average, 50 days
$32.18
$35.62
Open
$32.03
Previous close
$31.06
52-week high
$43.73
Dec 8, 2025 (1 year ago)
52-week low
$13.93
Nov 7, 2025 (13 months ago)
126.06%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
5.46B
Volume
2 228 083
Total Return (3M)
-26.49%
Total Return (1Y)
122.86%
6.78
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
cogentbio.com
Socials
About
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.

Frequently asked questions

COGT · Cogent Biosciences, Inc.

01What is Cogent Biosciences, Inc. stock price today?

The current price of COGT is $31.49 — it has increased by 1.38% since the previous close. Data as of Nov 4, 2026.

02Is Cogent Biosciences, Inc. stock price growing?

COGT is down 0.82% over the past week, up 1.52% over the past month and up 122.86% over the past year. The price is below its 200-day moving average of $35.62.

03What do analysts say about COGT stock?

Of the 12 analysts covering Cogent Biosciences, Inc., 2 rate it a strong buy, 9 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

04What is Cogent Biosciences, Inc. market cap?

Cogent Biosciences, Inc. has a market capitalization of $5.46B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

05What were Cogent Biosciences, Inc. earnings last quarter?

In its most recent quarterly report, Cogent Biosciences, Inc. posted a loss of $0.52 per share against an estimate of -$0.555, beating expectations by 6.30%. Upcoming reports are listed in the earnings calendar.

06Does Cogent Biosciences, Inc. pay dividends?

Cogent Biosciences, Inc. has not paid any dividends over the past year.

07How volatile is COGT stock?

In the latest trading session COGT moved between $29.94 and $32.03, a range of 6.65% of its current price.

08Should I invest in Cogent Biosciences, Inc. stock?

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Cogent Biosciences, Inc. shows a buy rating today. Technical ratings are indicators, not investment advice.

09What are COGT stock 52-week high and low?

Over the past 52 weeks COGT has traded between $13.93 and $43.73. The current price is 27.99% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.